← Back to Clinical Trials
Recruiting NCT07746297

NCT07746297 The PANHIS Study: Sexual Health in Spanish-Speaking Adults - A Cross-Sectional Online Survey

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07746297
Status Recruiting
Phase
Sponsor Menoclinica by Palacios
Condition Sexual Health
Study Type OBSERVATIONAL
Enrollment 15,000 participants
Start Date 2026-08-30
Primary Completion 2026-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 15,000 participants in total. It began in 2026-08-30 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This cross-sectional observational study uses an online survey to describe the epidemiology of sexual health, sexual behaviour and sexual function in Spanish-speaking adults, and to estimate the prevalence and phenomenology of expanded (altered) states of consciousness associated with orgasm. The study has two prespecified aims, analysed and reported as two separate manuscripts: 1. sexual health and behaviour epidemiology and associated factors; and 2. expanded states of consciousness associated with orgasm. Recruitment is via social media with complementary channels. Sexual function is assessed with a brief study-developed instrument administered identically to all participants, enabling direct between-sex comparison. Survey weights are applied. Reporting follows STROBE and CHERRIES.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years (self-reported) * Sufficient command of Spanish to understand and respond to the questionnaire * Internet access and a device compatible with the digital survey form * Explicit informed consent provided digitally before accessing the questionnaire Exclusion Criteria: * Refusal of informed consent * Questionnaire completion rate below 70% (the threshold also required to access the participation incentive) * Duplicate response, identified by exact email match (when provided) or by analysis of response patterns and technical fingerprint (timestamp, IP address, user agent) * Implausible response patterns (e.g., age of sexual debut greater than current age, systematic straight-lining on reverse-coded scales, completion times below the first percentile of the pilot) - Aged under 18

Contact & Investigator

Central Contact

Silvia P González Rodríguez, MD, PhD, MSc

✉ silviapgonzalez@menoclinica.com

📞 +34621192307

Principal Investigator

Silvia P. González Rodríguez, MD, PhD, MSc

PRINCIPAL INVESTIGATOR

Universidad Europea del Atlántico

Frequently Asked Questions

Who can join the NCT07746297 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Sexual Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07746297 currently recruiting?

Yes, NCT07746297 is actively recruiting participants. Contact the research team at silviapgonzalez@menoclinica.com for enrollment information.

Where is the NCT07746297 trial being conducted?

This trial is being conducted at Santander, Spain, Madrid, Spain.

Who is sponsoring the NCT07746297 clinical trial?

NCT07746297 is sponsored by Menoclinica by Palacios. The principal investigator is Silvia P. González Rodríguez, MD, PhD, MSc at Universidad Europea del Atlántico. The trial plans to enroll 15,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology